14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.97 $4.17 Wednesday, 24th Apr 2024 CLRB stock ended at $3.06. This is 1.61% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 5.83% from a day low at $3.00 to a day high of $3.18.
90 days $2.97 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Sep 24, 2020 $1.19 $1.21 $1.16 $1.17 156 377
Sep 23, 2020 $1.29 $1.29 $1.17 $1.20 350 122
Sep 22, 2020 $1.19 $1.29 $1.16 $1.28 451 443
Sep 21, 2020 $1.23 $1.24 $1.16 $1.19 271 203
Sep 18, 2020 $1.19 $1.30 $1.18 $1.21 478 842
Sep 17, 2020 $1.18 $1.25 $1.18 $1.22 174 229
Sep 16, 2020 $1.26 $1.27 $1.18 $1.22 321 626
Sep 15, 2020 $1.23 $1.28 $1.21 $1.24 498 102
Sep 14, 2020 $1.16 $1.20 $1.13 $1.20 366 646
Sep 11, 2020 $1.11 $1.15 $1.10 $1.11 111 696
Sep 10, 2020 $1.13 $1.16 $1.09 $1.12 289 069
Sep 09, 2020 $1.06 $1.25 $1.05 $1.16 590 020
Sep 08, 2020 $1.07 $1.09 $1.03 $1.06 220 306
Sep 04, 2020 $1.11 $1.12 $1.01 $1.08 437 496
Sep 03, 2020 $1.11 $1.14 $1.06 $1.09 359 263
Sep 02, 2020 $1.13 $1.14 $1.10 $1.13 336 779
Sep 01, 2020 $1.16 $1.19 $1.13 $1.14 416 678
Aug 31, 2020 $1.22 $1.24 $1.14 $1.19 546 123
Aug 28, 2020 $1.20 $1.25 $1.20 $1.20 152 028
Aug 27, 2020 $1.23 $1.26 $1.18 $1.20 349 207
Aug 26, 2020 $1.20 $1.30 $1.20 $1.23 349 729
Aug 25, 2020 $1.20 $1.30 $1.16 $1.20 813 494
Aug 24, 2020 $1.18 $1.20 $1.12 $1.16 824 965
Aug 21, 2020 $1.20 $1.23 $1.17 $1.18 503 164
Aug 20, 2020 $1.29 $1.30 $1.20 $1.22 810 389
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT